Evidence map›Paper›PMID 21376639›Full record

ArticleImmunity2011

A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells.

Kwok S Wun, Garth Cameron, Onisha Patel, Siew Siew Pang, Daniel G Pellicci, Lucy C Sullivan, Santosh Keshipeddy, Mary H Young, Adam P Uldrich, Meena S Thakur and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 113 citations in OpenAlex.

  1. Lipidomic scanning of self-lipids identifies headless antigens for natural killer T cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  2. Review
  3. Article
  4. Glycolipids from the gut symbiontChemical science · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 3 countries.

Kwok S WunThe Protein Crystallography Unit, ARC Centre of Excellence in Structural and Functional Microbial Genomics, Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria 3800, Australia.
Garth Cameron
Onisha Patel
Siew Siew Pang
Daniel G Pellicci
Lucy C Sullivan
Santosh Keshipeddy
Mary H Young
Adam P Uldrich
Meena S Thakur
Stewart K Richardson
Amy R Howell
Petr A Illarionov
Andrew G Brooks
Gurdyal S Besra
James McCluskey
Laurent Gapin
Steven A Porcelli
Dale I Godfrey
Jamie Rossjohn
University of Melbourne · AUMonash University · AUUniversity of Connecticut · USUniversity of Birmingham · GBUniversity of Colorado Denver · USAlbert Einstein College of Medicine · US

Funding

TRAINING PROGRAM IN IMMUNOLOGYT32AI007405 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Laurel L Lenz, Raul Martin Torres · 1991 to 2026
$10.5M
Precision Targeting of CD1-Restricted iNKT Cells for Cancer ImmunotherapyR01AI045889 · NIAID · YESHIVA UNIVERSITY · PI Steven A Porcelli · 1999 to 2026
$9.3M
Harnessing NKT Cell Activation by GlycolipidsR01GM087136 · NIGMS · UNIVERSITY OF CONNECTICUT STORRS · PI HOWELL, AMY · 2009 to 2010
$536k
Structural Requirements of glycolipid/CD1d Recognition by NKT CellsR56AI078246 · NIAID · UNIVERSITY OF COLORADO DENVER · PI GAPIN, LAURENT · 2009 to 2010
$451k
Visualization of Va14i NKT cells in vivoR21AI076463 · NIAID · UNIVERSITY OF COLORADO DENVER · PI GAPIN, LAURENT · 2008 to 2009
$361k
NIAID NIH HHS AI076463NIAID NIH HHS AI078246NIAID NIH HHS AI45889NIAID NIH HHS R01 AI045889NIAID NIH HHS R21 AI076463NIAID NIH HHS R56 AI078246NIAID NIH HHS T32 AI007405NIAID NIH HHS T32 AI07405NIGMS NIH HHS R01 GM087136NIGMS NIH HHS R01GM087136
6 · The paper itself

Abstract

Natural killer T (NKT) cells respond to a variety of CD1d-restricted antigens (Ags), although the basis for Ag discrimination by the NKT cell receptor (TCR) is unclear. Here we have described NKT TCR fine specificity against several closely related Ags, termed altered glycolipid ligands (AGLs), which differentially stimulate NKT cells. The structures of five ternary complexes all revealed similar docking. Acyl chain modifications did not affect the interaction, but reduced NKT cell proliferation, indicating an affect on Ag processing or presentation. Conversely, truncation of the phytosphingosine chain caused an induced fit mode of TCR binding that affected TCR affinity. Modifications in the glycosyl head group had a direct impact on the TCR interaction and associated cellular response, with ligand potency reflecting the t(1/2) life of the interaction. Accordingly, we have provided a molecular basis for understanding how modifications in AGLs can result in striking alterations in the cellular response of NKT cells.

Indexed as

EpitopesAnimalsAntigens, CD1dCarbohydrate SequenceCell LineCell ProliferationGlycolipidsMiceMice, Inbred C57BLModels, MolecularMolecular Sequence DataNatural Killer T-CellsReceptors, Natural Killer CellAntigens, CD1dEpitopesGlycolipidsReceptors, Natural Killer Cell

Identifiers

PMID21376639
PMCPMC3064745
OpenAlexW2116232985

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.